plumbagin has been researched along with Carcinoma, Large Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, KY; Liu, G; Shao, Y; Xu, YY; Yu, T; Zhang, YY | 1 |
1 other study(ies) available for plumbagin and Carcinoma, Large Cell
| Article | Year |
|---|---|
Plumbagin suppresses the human large cell lung cancer cell lines by inhibiting IL-6/STAT3 signaling in vitro.
Topics: Antineoplastic Agents; Carcinoma, Large Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Interleukin-6; Lung Neoplasms; Naphthoquinones; Phosphorylation; Signal Transduction; STAT3 Transcription Factor | 2018 |